Spain· ES:1201446001IP
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE
A medicinal product containing bulevirtida, registered in Spain by Gilead Sciences Ireland Unlimited Company.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- bulevirtida
- Manufacturer
- Gilead Sciences Ireland Unlimited Company
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 21, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bulevirtida in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHepcludex 2mg powder for solution for injection vialsGilead Sciences Ltd
- IcelandHepcludexGilead Sciences Ireland UC*
- NorwayHepcludexGilead Sciences Ireland UC
- PolandHepcludexGilead Sciences Ireland UC
- SwedenHEPCLUDEX 2 mg Pulver till injektionsvätska, lösningGilead Sciences Ireland UC
- SwitzerlandHepcludex
- FranceHEPCLUDEX 2 mg, poudre pour solution injectableGILEAD SCIENCES IRELAND UC (IRLANDE)
- IrelandHEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Hepcludex
- Liechtenstein · Hepcludex
- Norway · Hepcludex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b5154a9-89be-44f2-8a73-ff6dd7867354 GET /v1/drugs/3b5154a9-89be-44f2-8a73-ff6dd7867354?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1789388294000}",
"nregistro": "1201446001IP",
"substance": "bulevirtida"
}See everything about bulevirtida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.